CXL-1020, a Novel Nitroxyl (HNO) Prodrug, Is More Effective than Milrinone in Models of Diastolic Dysfunction-A Cardiovascular Therapeutic: An Efficacy and Safety Study in the Rat.
about
CXL-1020, a Novel Nitroxyl (HNO) Prodrug, Is More Effective than Milrinone in Models of Diastolic Dysfunction-A Cardiovascular Therapeutic: An Efficacy and Safety Study in the Rat.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
CXL-1020, a Novel Nitroxyl (HN ...... y and Safety Study in the Rat.
@en
CXL-1020, a Novel Nitroxyl (HN ...... y and Safety Study in the Rat.
@nl
type
label
CXL-1020, a Novel Nitroxyl (HN ...... y and Safety Study in the Rat.
@en
CXL-1020, a Novel Nitroxyl (HN ...... y and Safety Study in the Rat.
@nl
prefLabel
CXL-1020, a Novel Nitroxyl (HN ...... y and Safety Study in the Rat.
@en
CXL-1020, a Novel Nitroxyl (HN ...... y and Safety Study in the Rat.
@nl
P2093
P2860
P356
P1476
CXL-1020, a Novel Nitroxyl (HN ...... y and Safety Study in the Rat.
@en
P2093
J Craig Hartman
John E Reardon
Mark T Ziolo
Reza Mazhari
Robert L Hamlin
Steve R Roof
Yukie Ueyama
P2860
P356
10.3389/FPHYS.2017.00894
P577
2017-11-10T00:00:00Z